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Abstract The amino acid sequence of cytochrome c peroxidase 
from Pseudomonas aeruginosa has been determined using classi- 
cal chemical degradation techniques combined with accurate 
mass analysis of all the generated peptides. The sequence ob- 
tained is composed of 346 amino acids and confirms the recently 
published cDNA-derived sequence xcept at one position [Ridout 
et al. (1995) FEBS Lett. 365, 152-154]. Based on this sequence, 
we propose a new model for the binding of the peroxide and the 
cytochrome lectron donor to CCP which is in essence the reverse 
of the one proposed by Ellfolk et ai. [Biochim. Biophys. Acta 1080 
(1991) 175-178]. 
Ke , words: Cytochrome c peroxidase; Pseudomonas 
aer~ginosa; Mass analysis; Primary structure 
1. Introduction 
'.ytochrome c peroxidase (CCP) from Pseudomonas erugi- 
no,~:~ (Pa) is the only bacterial CCP that has so far been se- 
quenced. R6nnberg et al. [1] originally reported that the poly- 
pel'.tide is 302 amino acids long containing two typical haem 
c-b,nding sites (Cys-X-Y-Cys-His), and that it had six positions 
whure the presence of two residues betrayed micro heterogene- 
ity. In a subsequent paper, Ellfolk et al. [2] corrected this se- 
quence by reducing the number of heterogeneous positions to 
two. The authors proposed that the first half of the polypeptide 
chain contains the low potential haem-binding region that re- 
act.. with the hydrogen peroxide, and that the second half con- 
taft,s the high potential haem-binding region that interacts with 
the reduced electron donor protein of CCP. Carrying out high 
pre,=ision mass analysis of Pa CCP, we recently noticed that its 
mo ecular mass is some 2 kDa higher than the calculated mass 
of I he amino acid sequence published by Ellfolk et al. [2]. We 
now report the complete amino acid sequence of PaCCP, in- 
cluding the proof of the covalent linkage of the two haem 
groaps, based on the evidence obtained from Edman degrada- 
t io l  in combination with mass analysis of the sequenced pep- 
tides. The data correct he original sequence at several positions 
including, as a major point, the presence of an additional sec- 
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Abb,'eviations: RPLC, reversed-phase liquid chromatography; ESMS, 
electrospray mass spectrometry; MALDI, matrix-assisted laser desorp- 
tion mass spectrometry. 
tion of nineteen residues. Our results were presented at the 
Protein Society Meeting held in Davos, Switzerland, from 28 
May to 1 June 1995. Shortly thereafter, Ridout et al. [3] re- 
ported the nucleotide sequence of PaCCP which is in agreement 
with our sequence xcept at one position. 
2. Methods and materials 
2.1. Enzymatic and chemical c eavages 
About 1 nmol holo CCP was digested with endoproteinase Lys-C 
(Boehringer, Mannheim, Germany) (50 mM Tris-HC1, pH 8.0, E/S = 1/ 
40, 7.5 h, 37°C). A second cleavage was performed by partial acid 
hydrolysis on about 2 nmol holo CCP for 3 h at 106°C (this cleavage 
was performed twice). A final digest was performed with endopro- 
teinase GIu-C (Boehringer) on 6 nmol apo-CCP (100 mM NH4HCO3, 
pH 7.6, E/S = 1/40. One GIu-C peptide was subjected to a subdigest 
with endoproteinase Arg-C (Boehringer). The subdigest was carried out 
according the instructions given by the company. 
2.2. Peptide purification 
Half of the peptide material resulting from the Lys-C-digest and from 
the partial acid hydrolysis was subjected to RPLC analysis on a Se- 
phasil C~8 column (2.1 x 100 mm) (Pharmacia, Uppsala, Sweden) using 
a gradient of solvent A (0.05% TFA in water) and solvent B (0.04% 
TFA in 80% ACN). The peptides from the Glu-C-digest were purified 
using a fast desalting column (PC 3.2 × 100 mm) (Pharmacia) eluted 
with 5% formic acid. The first peak, containing two larger peptides, was 
subjected to RPLC on a TMS column (BioRad, Nazareth Eke, Bel- 
gium); the smaller peptides in the second gel filtration fraction were 
separated on a mRPC C2/C,8 column (2.1 x 100 mm, Pharmacia). Pep- 
tides from the Arg-C subdigest were separated on a Sephasil C8 column 
(2.1 x 100 mm) (Pharmacia) and eluted with a linear gradient of water/ 
ACN. Peptides were detected by UV absorbance at 220 and 280 nm. 
The separation of the second half of the peptide mixtures from the 
Lys-C digest and the partial acid hydrolysis was performed by on-line 
LCMS. The system was described in detail by Klarskov et al. [5]. 
2.3. Sequence analysis 
Sequence analysis was performed on the models 477A and 476A 
pulsed liquid-phase sequenators with on-line PTH analysis on a 120A 
analyser (Applied Biosystems, Foster City, CA). Sequencing reagents 
and solvents were obtained from the same firm. 
2.4. Mass spectrometry 
All LCMS analyses were performed on a BIO-Q triple-quadrupole 
mass spectrometer equipped with a pneumatically assisted electrospray 
source (Fisons, Altrincham, UK) operating in the positive ion mode. 
Some peptides were also subjected to MALDI-TOF analysis. The sam- 
ples were analysed on a VG Tofspec (Fisons, VG Analytical, Wythen- 
shawe, UK) equipped with a Nitrogen laser [6]. 
3. Results 
The study started by analysing the mass of native PaCCP 
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Fir. 2. (A) RPLC separation (SMART) of the Lys-C peptides of native 
PaCCE The gradient profile of solvent Bis indicated ( . . . . .  ). Numbers 
designate the resulting peptides. (B) On-line LCMS analysis of the 
L) ,-C peptides of native PaCCE The y-axis represents he base peak 
int,~nsity of the measured ion current (BPI), the x-axis represents the 
nu~nber ofmass pectra cquired uring the chromatographic analysis. 
Nt tubers designate he resulting peptides. 
using both ESMS and LDMS (36,251.4 Da and 36,215.3 Da, 
respectively, data not shown). These masses indicated that the 
polypeptide is actually some 20 residues longer than the se- 
quence published by R6nnberg et al. [1]. Fig. 1 shows the 
coTnplete sequence of PaCCE N-terminal sequence analysis of 
thtr native protein revealed the identity of the first 45 amino 
acids and the presence of a minor fragment (20%) starting at 
position Val-224, apparently originating from a Ser-Val cleav- 
ag.:. Subsequently, the holoprotein was cleaved with Lys-C 
endoproteinase as well as by partial acid hydrolysis (5% formic 
acid). Both peptide mixtures were separated by RPLC as given 
under section 2 (Fig. 2A gives the result for the Lys-C digest) 
as well as by mass analysis of the eluted peptides by LCMS (Fig. 
2B). Peptides Kc SM 12a and Kc LCMS 10b appeared to 
contain sequence information that was not presented previ- 
ously [1,2]. Fraction AH2 4, through one of its component 
peptides (4a), linked the peptides Kc SM 12a and Kc LCMS 
10b. Mass analysis of this peptide yielded a value of 3415.6 Da 
corresponding with the calculated mass 3414.8 Da (Asn-64~ 
Trp-94) and confirming the presence of the peptide section 
Asn-79-Arg-97. In order to prove the remaining overlaps, a 
Glu-C endoproteinase digest was performed on the apoprotein. 
Two larger fragments of, respectively, 82 (Ala-161-Glu-242) 
and 71 (Leu-33 Glu-103) amino acids were separated by gel 
filtration analysis and further purified by reversed-phase 
HPLC. The measured mass of the 82 residue peptide (8878.4 
Da) was approximately 200 Da higher than the calculated value 
(8679.8 Da). This extra mass is due to a Hg-atom bound to one 
of the cysteine residues 197 or 200, originating from the method 
of haem removal [7]. The second large peptide fraction (Leu- 
33-Glu-103) was subdigested with endoproteinase Arg-C and 
yielded the peptides Rc2 and Rcl which proved the overlap for 
the Kc and AH peptides found in the region Asn-90-Glu-103. 
4. Discussion 
The molecular mass calculated from the proposed sequence 
supplemented with two covalently bound haem groups is 
36,234.3 Da. The difference of 17.1 Da with the ESMS value 
of 36,251.4 Da betrays the presence of an oxidized residue, most 
likely of a methionine. The combination of the mass data (Ta- 
bles 1 and 2) with the sequence data of the individual peptides, 
I~ HP 
e" 
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Nt ct  Nt Ct 
e-  
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Fig. 3. Models for the mechanism of action of PaCCE (A) Model 
proposed by Ellfolk et al. [2]; (B) model deduced from the revised 
sequence (this work). HP and LP indicate high and low potential haems, 
respectively. Nt and Ct represents he first and second half of the 
protein. The peroxide-binding site is indicated by the reagent H202. 
6- -  
F i r .  1. The complete amino acid sequence ofCCP from P aeruginosa. Peptides obtained by digestion of the native protein with endoproteinase Lys-C 
separated by RPLC on the SMART system or by LCMS are indicated as Kc SM and Kc LCMS, respectively. Similarly, peptides obtained after 
partial acid hydrolysis of the nativew protein are shown as AH 1 SM or AH 1 LCMS. Peptides AH2 resulted from the second partial acid hydrolysis 
we~'e separated by RPLC analysis. Peptides of the apoprotein digested with endoproteinase GIu-C and separated by gel filtration and RPLC analysis 
have the label Ec GF. The peptide Ec GF1 fraction TMS 2 was subdigested with endoproteinase Arg-C and the resulting peptides are shown as Ec 
GH 2 Rc. Only those peptides are shown which were considered tobe essential for deducing the sequence. Residues indicated in bold are corrections 
and/or insertions with respect to the first sequence published [1]. 
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Table 1 
Mass spectrometric results of Lys-C peptides by MALDI analysis after RPLC separation (A) and by ESMS analysis after LCMS separation (B) 
Sequence position Calculated mass (A) Fractions from SMART (B) Fractions from LCMS 
Fraction MALDI Fraction ESMS 
Ala-18(~Lys-186 772.8 
Phe-233 Lys-237 564.7 
Lys-219-Lys-230 1213.4 
Leu-310-Glu-316 729.8 
Tyr-132-Lys-138 898.0 
Ser-262 Glu-267 704.7 
Thr-317-Glu-323 770.8 1 771.7 
Gly-107Glu-ll4 842.9 3 843.8 
Leu-154-Thr-165 1293.5 4 1295.8 
Ser-l17-Leu-126 1115.2 7 a 1114.4 
Thr-25~His-261 735.8 b 737.2 
Phe-93-Arg-97 679.7 8 a 679.9 
Gln-17-Glu-28 1356.5 b 1357.4 
Met-l15-Glu-123 1041.2 9 7 
Asp-171Lys-175 650.8 8 
Thr-238-Arg-246 1144.2 11 a 1143.9 9 
Ala-143- b 
Asn-79 Phe-84 663.7 12 a 10 a 
Asn-89-Lys-99 1263.4 b 1263.4 b 
Asp-270-Lys-282 1287.5 13 a 1286.5 11 a 
Asn-89 Arg-97 1064.1 b 1064.2 b 
Ser-262-Lys-269 946.1 14 a 947.7 12 a 
Asp-270-Lys-282 1287.5 b 1288.2 b 
Thr-25~Glu-267 1421.5 15 a 1422.3 13 a 
Leu-163 Leu-174 1379.6 b 1378.3 b 
Asp-l-Glu-16 1752.0 14 
Gln-124-Lys-138 1724.0 16 15 
Ser-46-Lys-75 3679.2 17 16 
Ala-191-Lys-218 3521.2 17 
Ala-191-Phe-214 3123.6 18 
1 772.4 
2 565.6 
3 1212.9 
4 730.9 
5 898.0 
6 705.6 
1040.9 
651.8 
1144.6 
664.8 
1287.0 
1064.6 
946.8 
1422.4 
1751.7 
1723.5 
3678.7 
3520.0 
3122.7 
For the sequence-derived molecular mass calculation, the residual masses (monoisotopic values) of the individual amino acids were used ( , not found 
in mass spectrum). 
Table 2 
Mass spectrometric data for peptides resulting from the first partial 
acid hydrolysis by MALDI analysis after RPLC separation (A) and 
ESMS analysis after LCMS separation (B) 
(A) Fractions from SMART 
Peptide Sequence position Calculated mass MALDI 
2 a Asn-151 Ala-180 3240.6 3241.6 
b Leu-101-Val-113 1340.5 1341.9 
3 a Val-289 Glu-323 3848.4 3851.6 
b Pro-41- 
4 a Asp-288-Glu-323 3963.5 3963.3 
b Ala- 135-Val- 152 1979.3 1980.0 
c Ash-64- 
5 Val-289 Gly-301 1385.6 1386.2 
6 Ala-271 -Glu-323 5642.4 5641.7 
(B) Fractions from LCMS 
Peptide Sequence position Calculated mass ESMS 
1 Gly-9~Lys-99 430.5 430.8 
2 a Ala-222-Gly-228 629.7 630.6 
b Ser-168 Asp-171 464.5 465.4 
3 Leu- 172-Asp- 178 822.9 822.6 
4 Ala-135-Phe-149 1651.0 1651.2 
5 a Ala-271-Pro-286 1581.9 1582.2 
b Ala-271-Asp-287 1697.0 1698.0 
6 Ala-2-Phe-39 4351.0 4351.6 
7 a Val-289-Glu-323 3848.4 3848.9 
b Ala-135-Asp-167 3538.0 3537.8 
Sequence derived masses were calculated as stated in Table 1. 
however, leave no doubt that the sequence given in Fig. 1 is 
correct. Our work is in agreement with the sequence deduced 
from the gene [3], including as a major point, the 19 residue 
insertion (Asn-79-Arg-97). At one position, residue 152, we 
find a valine whereas it is a methionine in the gene sequence. 
The presence of a Val was unambiguously proven by sequence 
analysis of peptides AH1 SM 2a and AH2 4d as well as by mass 
spectrometric analysis of peptides AH1 LCMS 7b, AH1 SM 2a 
and AH1 SM 4b (Table 2). It is possible that the difference may 
be due to the use of a different strain in both investigations. 
Whereas we used strain ATCC 10145 (- -NCTC 10332), Ridout 
et al. used strain ATCC 19429 ( - -NTCC 6750). 
Regardless of the identity of residue 152, the new sequence 
has important implications for the model of the mechanism of 
activity of PaCCP. Ellfolk et al. proposed a model based on the 
assumption that the polypeptide chain of PaCCP is folded as 
two linked single haem-binding domains of the mitochondrial 
cytochrome c type (Fig. 3A) [8]. Considering the standard spac- 
ing of 60 residues between the fifth and the sixth haem ligand 
for mitochondrial class I cytochromes, they did not see a puta- 
tive sixth haem ligand for the first haem group within the 
N-terminal domain. On the basis of NMR data, which suggest 
that the two haems would be in close contact o each other, the 
authors proposed that His-240 (261 in Fig. 1), situated in the 
C-terminal domain, might act as the sixth ligand and would 
therefore confer a low potential character to the first haem. 
Taking into account he 19 residues insertion in the N-terminal 
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d~main, we now see that Met-115, located 59 residues from 
His-55, becomes a very likely candidate as second haem ligand. 
C, msequently, we think that His-261, now freed from its pro- 
p~,sed role as ligand in the N-terminal domain, is the partner 
ligand for His-201 in the C-terminal domain again with a sepa- 
ration of 59 residues. This new model is shown in Fig. 3B. It 
c( nfers a high redox potential to the N-terminal domain which 
in eracts with the electron donor, cytochrome c-551, and a low 
re,tox potential to the C-terminal domain where the peroxide 
is bound. Alternatively, Met-275, instead of His-261, might act 
at the second ligand for the C-terminal domain. Bacterial cyto- 
cl tomes c2 of Class I are known where the spacing between the 
tv, o ligand residues is up to 80 residues (as e.g. in Paracoccus 
,fi ~itrificans cytochrome c-550 [9]). However, since a methion- 
in:  as the sixth ligand is nearly always associated with a high 
retox potential of the haem, this interpretation would imply 
tl~ it PaCCP has two haems with high redox potential which is 
in contrast with the observation that the haems act at redox 
p~ tentials differing as much as 600 mV [2]. Consequently, this 
se :ond possibility is less likely although there is a precedent for 
a low potential haem with a His-Met ligand structure [10]. 
F aally, we can not exclude the possibility of a mechanism in 
wuch Met-275 ligates the second haem site while His-116 li- 
g~tes the first haem. The relative configuration of the high and 
Io ~¢ redox potential sites would then be as originally suggested 
bx Ellfolk et al. [2]. 
Final proof for any of these proposals will of course have to 
ax 'air three-dimensional structure analysis of PaCCP but in the 
meantime the proposal for the mechanism of action of PaCCP 
is more likely to be that of Fig. 3B rather than that of Fig. 3A. 
Acknowledgements: This work has been supported by the Belgian Fund 
for Joint Basic Research (32001891) and a Concerted Research Action 
(12052293) from the Flemish Government. 
References 
[1] R6nnberg, M., Kalkkinen, N. and Ellfolk, N. (1989) FEBS Lett. 
250, 175-178. 
[2] Ellfolk, N., R6nnberg, M. and Osterlund, K. (1991) Biochim. 
Biophys. Acta 1080, 68 77. 
[3] Ridout, C.J., James, R. and Greenwood, C. (1995) FEBS Lett. 
365, 152 154. 
[4] Foote, N., Turner, R., Brittain, T. and Greenwood, C. (1992) 
Biochem. J. 283, 839-843. 
[5] Klarskov, K., Roecklin, D., Bouchon, B., Sabati6, J., Van Dorsse- 
laer, A. and Bisschoff, R. (1994) Analyt. Biochem. 216, 127 
134. 
[6] Hillenkamp, F., Karas, M., Beavis, R.C. and Chait, B.T. (1991) 
Anal. Chem. 63, 1193A-1203A. 
[7] Samyn, B., Berks, B.C., Page, M.D., Ferguson, S.S. and Van 
Beeumen, J.J. (1994) Eur. J. Biochem. 219, 585-594. 
[8] Moore, G.R. and Pettigrew, G.W. (1990) Cytochromes C: Evolu- 
tionary, Structural nd Physicochemical Aspects, Springer, Berlin, 
Germany. 
[9] Ambler, R.E, Meyer, T.E., Kamen, M.D., Schichman, S.A. and 
Sawyer, L. (1981) J. Mol. Biol. 147, 351-356. 
[10] Mc Lendon, G.L., Bagby, S., Charman, J.A., Driscoll, RC., McIn- 
tire, W.S., Mathews, F.S. and Hill, H.A.O. (1991) Proc. Natl. 
Acad. Sci. USA 88, 9463-9467. 
